SAREPTA THERAPEUTICS, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
SAREPTA THERAPEUTICS, INC. (SRPT) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $6.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-06-30 was $412.00K.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2026-03-31 was $5.95M, a 79.63% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-12-31 was -$2.24M, a 125.14% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2025-09-30 was -$20.77M, a 718.49% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2025 was $3.46M, a 91.90% decline from fiscal 2024.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2024 was $42.74M, a 28.20% increase from fiscal 2023.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2023 was $33.34M, a 392.82% increase from fiscal 2022.
- SAREPTA THERAPEUTICS, INC. noncash or part noncash acquisition, fixed assets acquired for fiscal 2022 was $6.76M, a 62.54% increase from fiscal 2021.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month as first filed | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month as first filed | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month as first filed | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 12 month as first filed | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 401 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 404 month |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $412.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $6.37M 10-Q · filed 2026-08-05 | $4.13M derived: sum of 3 quarters · filed 2026-08-05 | -$16.64M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2026-03-31 | $5.95M 10-Q · filed 2026-05-06 | $3.72M derived: sum of 2 quarters · filed 2026-05-06 | -$17.05M derived: sum of 3 quarters · filed 2026-05-06 | -$19.81M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-12-31 | -$2.24M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | -$23.01M derived: sum of 2 quarters · filed 2026-03-02 | -$25.77M derived: sum of 3 quarters · filed 2026-08-05 | $3.46M 10-K · filed 2026-03-02 | ||||||
| 2025-09-30 | -$20.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$23.53M derived: sum of 2 quarters · filed 2026-08-05 | $5.70M 10-Q · filed 2025-11-06 | $14.60M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-06-30 | -$2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $26.47M 10-Q · filed 2026-08-05 | $35.37M derived: sum of 3 quarters · filed 2026-08-05 | $38.72M derived: sum of 4 quarters · filed 2026-08-05 | ||||||
| 2025-03-31 | $29.23M 10-Q · filed 2026-05-06 | $38.12M derived: sum of 2 quarters · filed 2026-05-06 | $41.48M derived: sum of 3 quarters · filed 2026-05-06 | $49.04M derived: sum of 4 quarters · filed 2026-05-06 | ||||||
| 2024-12-31 | $8.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $12.26M derived: sum of 2 quarters · filed 2026-03-02 | $19.81M derived: sum of 3 quarters · filed 2026-03-02 | $42.74M 10-K · filed 2026-03-02 | ||||||
| 2024-09-30 | $3.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $10.91M derived: sum of 2 quarters · filed 2025-11-06 | $33.84M 10-Q · filed 2025-11-06 | $51.12M derived: sum of 4 quarters · filed 2026-03-02 | ||||||
| 2024-06-30 | $7.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $30.48M 10-Q · filed 2025-08-06 | $47.76M derived: sum of 3 quarters · filed 2026-03-02 | $42.89M derived: sum of 4 quarters · filed 2026-03-02 | ||||||
| 2024-03-31 | $22.93M 10-Q · filed 2025-05-06 | $40.21M derived: sum of 2 quarters · filed 2026-03-02 | $35.34M derived: sum of 3 quarters · filed 2026-03-02 | $45.13M derived: sum of 4 quarters · filed 2026-03-02 | ||||||
| 2023-12-31 | $17.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $12.41M derived: sum of 2 quarters · filed 2026-03-02 | $22.20M derived: sum of 3 quarters · filed 2026-03-02 | $33.34M 10-K · filed 2026-03-02 | ||||||
| 2023-09-30 | -$4.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $4.92M derived: sum of 2 quarters · filed 2024-11-06 | $16.06M 10-Q · filed 2024-11-06 | $17.31M derived: sum of 4 quarters · filed 2025-02-28 | ||||||
| 2023-06-30 | $9.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $20.93M 10-Q · filed 2024-08-07 | $22.18M derived: sum of 3 quarters · filed 2025-02-28 | $21.94M derived: sum of 4 quarters · filed 2025-02-28 | ||||||
| 2023-03-31 | $11.14M 10-Q · filed 2024-05-01 | $12.39M derived: sum of 2 quarters · filed 2025-02-28 | $12.15M derived: sum of 3 quarters · filed 2025-02-28 | $13.49M derived: sum of 4 quarters · filed 2025-02-28 | ||||||
| 2022-12-31 | $1.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $1.01M derived: sum of 2 quarters · filed 2025-02-28 | $2.35M derived: sum of 3 quarters · filed 2025-02-28 | $6.76M 10-K · filed 2025-02-28 | ||||||
| 2022-09-30 | -$240.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $1.10M derived: sum of 2 quarters · filed 2023-11-01 | $5.51M 10-Q · filed 2023-11-01 | $5.03M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-06-30 | $1.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $5.75M 10-Q · filed 2023-08-02 | $5.27M derived: sum of 3 quarters · filed 2024-02-28 | $2.15M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2022-03-31 | $4.42M 10-Q · filed 2023-05-02 | $3.93M derived: sum of 2 quarters · filed 2024-02-28 | $817.00K derived: sum of 3 quarters · filed 2024-02-28 | $2.85M derived: sum of 4 quarters · filed 2024-02-28 | ||||||
| 2021-12-31 | -$482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$3.60M derived: sum of 2 quarters · filed 2024-02-28 | -$1.57M derived: sum of 3 quarters · filed 2024-02-28 | $4.16M 10-K · filed 2024-02-28 | ||||||
| 2021-09-30 | -$3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$1.08M derived: sum of 2 quarters · filed 2022-11-02 | $4.64M 10-Q · filed 2022-11-02 | $1.50M derived: sum of 4 quarters · filed 2023-02-28 | ||||||
| 2021-06-30 | $2.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $7.76M 10-Q · filed 2022-08-02 | $4.62M derived: sum of 3 quarters · filed 2023-02-28 | $3.88M derived: sum of 4 quarters · filed 2023-02-28 | ||||||
| 2021-03-31 | $5.73M 10-Q · filed 2022-05-04 | $2.59M derived: sum of 2 quarters · filed 2023-02-28 | $1.85M derived: sum of 3 quarters · filed 2023-02-28 | $4.73M derived: sum of 4 quarters · filed 2023-02-28 | ||||||
| 2020-12-31 | -$3.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.88M derived: sum of 2 quarters · filed 2023-02-28 | -$1.00M derived: sum of 3 quarters · filed 2023-02-28 | $5.15M 10-K · filed 2023-02-28 | ||||||
| 2020-09-30 | -$740.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $2.14M derived: sum of 2 quarters · filed 2021-11-03 | $8.29M 10-Q · filed 2021-11-03 | $7.27M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2020-06-30 | $2.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $9.03M 10-Q · filed 2021-08-04 | $8.01M derived: sum of 3 quarters · filed 2022-03-01 | $7.21M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2020-03-31 | $6.15M 10-Q · filed 2021-05-05 | $5.14M derived: sum of 2 quarters · filed 2022-03-01 | $4.33M derived: sum of 3 quarters · filed 2022-03-01 | $4.36M derived: sum of 4 quarters · filed 2022-03-01 | ||||||
| 2019-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.82M derived: sum of 2 quarters · filed 2022-03-01 | -$1.80M derived: sum of 3 quarters · filed 2022-03-01 | $1.31M 10-K · filed 2022-03-01 | $1.18M 10-K · filed 2020-02-26 | |||||
| 2019-09-30 | -$801.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$781.00K derived: sum of 2 quarters · filed 2020-11-05 | $2.33M 10-Q · filed 2020-11-05 | $2.12M 10-Q · filed 2019-11-07 | $5.61M derived: sum of 4 quarters · filed 2021-03-01 | |||||
| 2019-06-30 | $20.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.13M 10-Q · filed 2020-08-05 | $2.90M 10-Q · filed 2019-08-07 | $6.41M derived: sum of 3 quarters · filed 2021-03-01 | $8.63M derived: sum of 4 quarters · filed 2021-03-01 | |||||
| 2019-03-31 | $3.11M 10-Q · filed 2020-05-06 | $2.88M 10-Q · filed 2019-05-08 | $6.39M derived: sum of 2 quarters · filed 2021-03-01 | $8.61M derived: sum of 3 quarters · filed 2021-03-01 | $5.92M derived: sum of 4 quarters · filed 2021-03-01 | |||||
| 2018-12-31 | $3.28M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $5.51M derived: sum of 2 quarters · filed 2021-03-01 | $2.81M derived: sum of 3 quarters · filed 2021-03-01 | $5.79M 10-K · filed 2021-03-01 | $5.42M 10-K · filed 2019-02-28 | |||||
| 2018-09-30 | $2.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$465.00K derived: sum of 2 quarters · filed 2019-11-07 | $2.52M 10-Q · filed 2019-11-07 | $4.66M derived: sum of 4 quarters · filed 2020-02-26 | ||||||
| 2018-06-30 | -$2.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $289.00K 10-Q · filed 2019-08-07 | $2.43M derived: sum of 3 quarters · filed 2020-02-26 | |||||||
| 2018-03-31 | $2.98M 10-Q · filed 2019-05-08 | $5.12M derived: sum of 2 quarters · filed 2020-02-26 | ||||||||
| 2017-12-31 | $2.14M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $2.52M 10-K · filed 2020-02-26 | ||||||||
| 2017-09-30 | $385.00K 10-Q · filed 2018-10-31 | |||||||||
| 2017-03-31 | $330.00K 10-Q · filed 2018-05-03 | |||||||||
| 2016-12-31 | $1.19M 10-K · filed 2019-02-28 | |||||||||
| 2016-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $99.00K 10-Q · filed 2017-08-03 | $206.00K derived: sum of 3 quarters · filed 2018-03-01 | |||||||
| 2016-03-31 | $19.00K 10-Q · filed 2017-05-04 | $126.00K derived: sum of 2 quarters · filed 2018-03-01 | ||||||||
| 2015-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $318.00K 10-K · filed 2018-03-01 | ||||||||
| 2015-09-30 | $211.00K 10-Q · filed 2016-11-07 | |||||||||
| 2015-03-31 | $45.00K 10-Q · filed 2016-05-05 | -$843.00K derived: sum of 2 quarters · filed 2017-02-28 | -$100.00K derived: sum of 3 quarters · filed 2017-02-28 | -$3.21M derived: sum of 4 quarters · filed 2017-02-28 | ||||||
| 2014-12-31 | -$888.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$145.00K derived: sum of 2 quarters · filed 2017-02-28 | -$3.26M derived: sum of 3 quarters · filed 2017-02-28 | $277.00K 10-K · filed 2017-02-28 | ||||||
| 2014-09-30 | $743.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$2.37M derived: sum of 2 quarters · filed 2015-11-05 | $1.17M 10-Q · filed 2015-11-05 | $5.13M derived: sum of 4 quarters · filed 2016-02-25 | ||||||
| 2014-06-30 | -$3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | $422.00K 10-Q · filed 2015-08-06 | $4.39M derived: sum of 3 quarters · filed 2016-02-25 | $4.39M derived: sum of 4 quarters · filed 2016-02-25 | ||||||
| 2014-03-31 | $3.53M 10-Q · filed 2015-05-07 | $7.50M derived: sum of 2 quarters · filed 2016-02-25 | $7.50M derived: sum of 3 quarters · filed 2016-02-25 | $3.53M 10-Q · filed 2014-05-08 | ||||||
| 2013-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $3.96M derived: sum of 2 quarters · filed 2016-02-25 | $3.96M 10-K · filed 2016-02-25 | $3.96M 10-K · filed 2014-03-03 | ||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $0.00 10-Q · filed 2014-11-06 | ||||||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |